Treatment with the epigenetic modifying compound JQ1+ can significantly reduce the proliferation of pancreatic neuroendocrine tumours in a mouse model of multiple endocrine neoplasia type 1

2015 ◽  
Author(s):  
Kate E Lines ◽  
Mark Stevenson ◽  
Panagis Filippakopoulos ◽  
Susanne Muller ◽  
Stefan Knapp ◽  
...  
Keyword(s):  
Mouse Model ◽  
Multiple Endocrine Neoplasia ◽  
Neuroendocrine Tumours ◽  
Multiple Endocrine Neoplasia Type ◽  
Endocrine Neoplasia ◽  
Endocrine Neoplasia Type ◽  
Pancreatic Neuroendocrine Tumours

scholarly journals Challenges in diagnosing and treating pancreatic neuroendocrine tumours in patients with a multiple endocrine neoplasia type 1 (MEN1) syndrome

Oncoreview ◽  
2018 ◽  
Vol 8 (1) ◽  
pp. 42-47
Author(s):  
Natalia Rogozik ◽  
Agnieszka Kolasińska-Ćwikła ◽  
Jarosław B. Ćwikła ◽  
Andrzej Cichocki ◽  
Adam Przybyłkowski ◽  
...  
Keyword(s):  
Multiple Endocrine Neoplasia ◽  
Neuroendocrine Tumours ◽  
Multiple Endocrine Neoplasia Type ◽  
Men1 Syndrome ◽  
Endocrine Neoplasia ◽  
Endocrine Neoplasia Type ◽  
Pancreatic Neuroendocrine Tumours

scholarly journals Long-term outcomes in patients with multiple endocrine neoplasia type 1 and pancreaticoduodenal neuroendocrine tumours

2016 ◽  
Vol 86 (2) ◽  
pp. 199-206 ◽  
Author(s):  
D. Donegan ◽  
N. Singh Ospina ◽  
R. Rodriguez-Gutierrez ◽  
Z. Al-Hilli ◽  
G.B. Thompson ◽  
...  
Keyword(s):  
Multiple Endocrine Neoplasia ◽  
Neuroendocrine Tumours ◽  
Multiple Endocrine Neoplasia Type ◽  
Long Term Outcomes ◽  
Endocrine Neoplasia ◽  
Endocrine Neoplasia Type
Sign in / Sign up

Export Citation Format

Share Document